Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

1.

Anti-anaerobic potential of ranbezolid: insight into its mechanism of action against Bacteroides fragilis.

Mathur T, Kalia V, Barman TK, Singhal S, Khan S, Upadhyay DJ, Rattan A, Raj VS.

Int J Antimicrob Agents. 2013 Jan;41(1):36-40. doi: 10.1016/j.ijantimicag.2012.09.013. Epub 2012 Nov 9.

PMID:
23142085
[PubMed - indexed for MEDLINE]
2.

Antianaerobe activity of RBX 7644 (ranbezolid), a new oxazolidinone, compared with those of eight other agents.

Ednie LM, Rattan A, Jacobs MR, Appelbaum PC.

Antimicrob Agents Chemother. 2003 Mar;47(3):1143-7.

PMID:
12604558
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Mode of action of Ranbezolid against staphylococci and structural modeling studies of its interaction with ribosomes.

Kalia V, Miglani R, Purnapatre KP, Mathur T, Singhal S, Khan S, Voleti SR, Upadhyay DJ, Saini KS, Rattan A, Raj VS.

Antimicrob Agents Chemother. 2009 Apr;53(4):1427-33. doi: 10.1128/AAC.00887-08. Epub 2008 Dec 15.

PMID:
19075051
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

The in-vitro activity of linezolid (U-100766) and tentative breakpoints.

Wise R, Andrews JM, Boswell FJ, Ashby JP.

J Antimicrob Chemother. 1998 Dec;42(6):721-8.

PMID:
10052894
[PubMed - indexed for MEDLINE]
Free Article
5.

Activity of linezolid against anaerobic bacteria.

Behra-Miellet J, Calvet L, Dubreuil L.

Int J Antimicrob Agents. 2003 Jul;22(1):28-34.

PMID:
12842325
[PubMed - indexed for MEDLINE]
6.

Antipneumococcal and antistaphylococcal activities of ranbezolid (RBX 7644), a new oxazolidinone, compared to those of other agents.

Hoellman DB, Lin G, Ednie LM, Rattan A, Jacobs MR, Appelbaum PC.

Antimicrob Agents Chemother. 2003 Mar;47(3):1148-50.

PMID:
12604559
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Synthesis and SAR of novel oxazolidinones: discovery of ranbezolid.

Das B, Rudra S, Yadav A, Ray A, Rao AV, Srinivas AS, Soni A, Saini S, Shukla S, Pandya M, Bhateja P, Malhotra S, Mathur T, Arora SK, Rattan A, Mehta A.

Bioorg Med Chem Lett. 2005 Oct 1;15(19):4261-7.

PMID:
16054358
[PubMed - indexed for MEDLINE]
8.

[In vitro activity of an ofloxacin-metronidazole combination against anaerobic bacteria. Kinetics of the action of metronidazole against Bacteroides fragilis].

Dubreuil L, Devos J, Beerens H, Romond C.

Pathol Biol (Paris). 1988 May;36(5):488-92. French.

PMID:
3043345
[PubMed - indexed for MEDLINE]
9.

In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the Bacteroides fragilis group.

Snydman DR, Jacobus NV, McDermott LA.

Antimicrob Agents Chemother. 2008 Dec;52(12):4492-6. doi: 10.1128/AAC.00696-08. Epub 2008 Oct 6.

PMID:
18838581
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Antibacterial activities of tosufloxacin against anaerobic bacteria and the electron micrograph of its bactericidal effects.

Takahata M, Nishino T.

Chemotherapy. 1997 May-Jun;43(3):153-8.

PMID:
9142454
[PubMed - indexed for MEDLINE]
11.

Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.

Liu CY, Huang YT, Liao CH, Yen LC, Lin HY, Hsueh PR.

Antimicrob Agents Chemother. 2008 Sep;52(9):3161-8. doi: 10.1128/AAC.00355-08. Epub 2008 Jul 14.

PMID:
18625771
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

[Activity of doripenem against anaerobic bacteria].

Dubreuil L, Neut C, Mahieux S, Muller-Serieys C, Jean-Pierre H, Marchandin H, Soussy CJ, Miara A.

Pathol Biol (Paris). 2011 Apr;59(2):102-7. doi: 10.1016/j.patbio.2010.03.006. Epub 2010 May 26. French.

PMID:
20537808
[PubMed - indexed for MEDLINE]
13.

Bactericidal activity of ertapenem against major intra-abdominal pathogens.

Borbone S, Cascone C, Santagati M, Mezzatesta ML, Stefani S.

Int J Antimicrob Agents. 2006 Nov;28(5):396-401. Epub 2006 Oct 11.

PMID:
17045463
[PubMed - indexed for MEDLINE]
14.

Effect of aspoxicillin on anaerobic bacteria.

Ueno K, Watanabe K, Bunai M, Kobayashi T, Aoki M, Maezawa I, Sakuma Y, Yoshida H, Yamaguchi T.

Jpn J Antibiot. 1985 Jun;38(6):1516-28.

PMID:
3850132
[PubMed - indexed for MEDLINE]
15.

Antimicrobial therapy for anaerobic infections.

Finegold SM.

Scand J Gastroenterol Suppl. 1984;91:61-72.

PMID:
6588490
[PubMed - indexed for MEDLINE]
16.

Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model.

Moody JA, Fasching CE, Sinn LM, Gerding DN, Peterson LR.

J Lab Clin Med. 1990 Feb;115(2):190-5.

PMID:
1967626
[PubMed - indexed for MEDLINE]
17.

In vitro activity of RBx 7644 (ranbezolid) on biofilm producing bacteria.

Mathur T, Bhateja P, Pandya M, Fatma T, Rattan A.

Int J Antimicrob Agents. 2004 Oct;24(4):369-73.

PMID:
15380263
[PubMed - indexed for MEDLINE]
18.
19.

In vitro activities of levofloxacin, gatifloxacin, moxifloxacin and garenoxacin against Bacteroides fragilis strains evaluated by kill kinetics.

Schaumann R, Janssen E, Funke M, Stîngu CS, Genzel GH, Janssen M, Rodloff AC.

J Med Microbiol. 2013 Apr;62(Pt 4):576-81. doi: 10.1099/jmm.0.053280-0. Epub 2013 Jan 14.

PMID:
23319309
[PubMed - indexed for MEDLINE]
20.

Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007).

Snydman DR, Jacobus NV, McDermott LA, Golan Y, Hecht DW, Goldstein EJ, Harrell L, Jenkins S, Newton D, Pierson C, Rihs JD, Yu VL, Venezia R, Finegold SM, Rosenblatt JE, Gorbach SL.

Clin Infect Dis. 2010 Jan 1;50 Suppl 1:S26-33. doi: 10.1086/647940.

PMID:
20067390
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk